Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate CancerRelease Date:Education Oncology USA Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac eraRelease Date:Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRERelease Date:Research Hospital China, Hong Kong COVID-19 Disease Burden on the High Risk PopulationRelease Date:Education Vaccines All New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel DiseaseRelease Date:Research Inflammation & Immunology USA Actionable Biomarker and Genetic Testing in Cancer: Education for Advanced Practice Providers (APPs)Release Date:Education Oncology USA Unmet Needs and Emerging Data in Patients with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)Education Oncology USA Interdisciplinary Collaboration for the Management of Severe Alopecia Areata in Patients with ComorbiditiesRelease Date:Education Inflammation & Immunology USA Antimicrobial Stewardship in the Sub-Saharan African RegionRelease Date:Partner: International Society for Infectious DiseasesQuality Improvement Inflammation & Immunology All Enhancing Patient-Centered Outcomes in Emergency Department Migraine ManagementRelease Date:Partner: American College of Emergency Physicians (ACEP)Quality Improvement Internal Medicine USA Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Title Grant Type Focus Area Country Application Due Date Growth Hormone ResearchRelease Date:Research Rare Disease USA Efforts for early detection of atrial fibrillation and cardioembolic stroke preventionRelease Date:Quality Improvement Internal Medicine Japan Preventing cardiovascular diseases such as venous thromboembolism in cancer patients by raising awareness and promoting medicalRelease Date:Education Internal Medicine Japan Patient Registries In ATTR-CMRelease Date:Quality Improvement Rare Disease Japan Optimizing Menopausal Symptom Management in CanadaRelease Date:Quality Improvement Internal Medicine Canada Optimizing Menopausal Symptom Management in CanadaRelease Date:Quality Improvement Internal Medicine Canada Gene and Anti-TFPI Therapies in HemophiliaRelease Date:Research Rare Disease All Implementing Updated Pneumococcal Immunization Recommendations in AdultsRelease Date:Quality Improvement Vaccines USA Employment support / Lung CancerRelease Date:Education Oncology Japan Biomarker Testing / Lung CancerRelease Date:Education Oncology Japan Cachexia in Cancer – Educational Needs Assessment (USA, Canada, Japan, Italy, UK, Spain, Germany, France)Release Date:Education Internal Medicine Canada, France, Germany, Italy, Japan, Spain, USA, United Kingdom Addressing Knowledge Gaps in the Care of Patients with HR-positive/HER2-negative Advanced Breast CancerRelease Date:Education Oncology Japan